Clinical Trial Update: A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of BMS-986406 as monotherapy and in combination regimens in participants with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-986406 (BMS-986406)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED